Canon U.S.A. announced Thursday it has made a strategic investment in Ottawa-based Spartan Bioscience Inc. to fund research and development of new diagnostic testing products.
Canon’s wholly-owned subsidiary, Canon BioMedical Inc. is looking into ways it can work with Spartan on other products like rapid genetic testing.
“We are excited to continue our efforts as we move into new markets for rapid genetic testing,” Spartan CEO Paul Lem said in a statement. “Working with Canon will help accelerate our progress in the future.”
OBJ360 (Sponsored)
Nicole Arranz lights up whenever she sees or hears children visiting Perley Health’s east-end Ottawa campus. “My mom loves kids, and being around kids brings life to her,” said Josée
uOttawa grows Kanata North’s presence to meet rising innovation demands
When the University of Ottawa first opened its Kanata North Campus in the heart of Canada’s largest tech park, the goal was clear: To bring researchers, students, and industry closer
Seymour Liebman, who currently sits on Canon BioMedical’s board of directors will also join Spartan’s board.
“Spartan’s goals align with our mission to provide enhanced diagnostic testing systems that can help improve human health worldwide,” Mr. Liebman said in a statement.
Terms of the investment were not disclosed.
